在心脏发育和心脏疾病中的线粒素激活蛋白激酶
1Department of Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. yibinwang@mednet.ucla.edu
Circulation
|September 19, 2007
概括
线素激活蛋白 (MAP) 激酶在心脏健康和疾病中起着复杂的作用. 本综述总结了MAP激酶通路在心脏发育和病理学方面的最新发现,并探讨了它们的治疗潜力.
科学领域:
- 心血管生物学 心血管生物学
- 分子细胞生物学 分子细胞生物学
- 生物化学 生物化学
背景情况:
- 线素激活蛋白 (MAP) 激酶是关键的Ser-Thr蛋白激酶,参与各种生理功能.
- 关键的MAP激酶通路 (ERK1/2,JNK,p38,ERK5) 与心脏调节,发育和病理重塑有关.
- 激酶抑制剂和动物模型的最新进展为心脏MAP激酶功能提供了新的见解.
研究的目的:
- 审查最近关于MAP激酶子家族在心脏发育,缩和生存方面的研究.
- 解决有关特定MAP激酶在心脏病理学中的保护性或有害性作用的争议.
- 评估针对心脏病治疗的MAP激酶向的潜力.
主要方法:
- 关于心脏中MAP激酶通路的最近研究的文献综述.
- 从基因酶特异性抑制剂和基因工程动物模型中分析数据.
- 综合有关MAP激酶在心脏发育,缩和存活中的作用的信息.
主要成果:
- 在心脏过程中,MAP激酶通路具有多样化,有时甚至是相互矛盾的作用.
- 特定的MAP激酶可以在心脏病理条件下充当有害的促进剂或关键的保护剂.
- 显著的新见解已经出现,但关于它们的确切功能仍然存在争议.
结论:
- MAP 激酶通路是心脏功能的关键调节者,在疾病中具有复杂的作用.
- 向MAP激酶为心脏病提供了潜在的治疗策略,但需要仔细考虑特定的途径.
- 需要进一步的研究来解决现有的争议,并优化治疗方法.
更多相关视频
相关概念视频
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...